These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24708836)

  • 21. Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice.
    Zhu Y; Li ZL; Ding A; Yang H; Zhu WP; Cui TX; Zhang HT; Zhang H
    Drug Des Devel Ther; 2019; 13():3657-3667. PubMed ID: 31695333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats.
    Cervenka L; Wang CT; Mitchell KD; Navar LG
    Hypertension; 1999 Jan; 33(1):102-7. PubMed ID: 9931089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular manifestations of renovascular hypertension in diabetic mice.
    Kashyap S; Engel S; Osman M; Al-Saiegh Y; Wongjarupong A; Grande JP
    PeerJ; 2016; 4():e1736. PubMed ID: 26925344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current concepts of renal hemodynamics in diabetes.
    Anderson S; Vora JP
    J Diabetes Complications; 1995; 9(4):304-7. PubMed ID: 8573753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension.
    Warner GM; Cheng J; Knudsen BE; Gray CE; Deibel A; Juskewitch JE; Lerman LO; Textor SC; Nath KA; Grande JP
    Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1455-64. PubMed ID: 22378822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis.
    Pipinos II; Nypaver TJ; Moshin SK; Careterro OA; Beierwaltes WH
    J Vasc Surg; 1998 Jul; 28(1):167-77. PubMed ID: 9685143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal denervation reduces sympathetic overactivation, brain oxidative stress, and renal injury in rats with renovascular hypertension independent of its effects on reducing blood pressure.
    Nishi EE; Lopes NR; Gomes GN; Perry JC; Sato AYS; Naffah-Mazzacoratti MG; Bergamaschi CT; Campos RR
    Hypertens Res; 2019 May; 42(5):628-640. PubMed ID: 30573809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of renal atrophy in hypertensive patients: experience in Lille].
    Marboeuf P; Delsart P; Hurt C; Villers A; Hossein-Foucher C; Beregi JP; Deklunder G; Noel C; Mounier-Vehier C
    Presse Med; 2010 Apr; 39(4):e67-76. PubMed ID: 19854024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
    Mima A; Arai H; Matsubara T; Abe H; Nagai K; Tamura Y; Torikoshi K; Araki M; Kanamori H; Takahashi T; Tominaga T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-(1-7)-induced renal vasodilation is reduced in human kidneys with renal artery stenosis.
    Van Twist DJ; Houben AJ; De Haan MW; Mostard GJ; De Leeuw PW; Kroon AA
    J Hypertens; 2014 Dec; 32(12):2428-32; discussion 2432. PubMed ID: 25208127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in transgenic hypertensive mice carrying both human renin and angiotensinogen genes.
    Kai T; Kino H; Ishikawa K
    Hypertens Res; 1998 Mar; 21(1):39-46. PubMed ID: 9582107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for the management of special populations: renal disease in diabetes.
    Raij L
    Am J Hypertens; 2003 Nov; 16(11 Pt 2):46S-49S. PubMed ID: 14625161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
    Fabris B; Candido R; Armini L; Fischetti F; Calci M; Bardelli M; Fazio M; Campanacci L; Carretta R
    J Hypertens; 1999 Dec; 17(12 Pt 2):1925-31. PubMed ID: 10703891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naringenin Ameliorates Renovascular Hypertensive Renal Damage by Normalizing the Balance of Renin-Angiotensin System Components in Rats.
    Wang Z; Wang S; Zhao J; Yu C; Hu Y; Tu Y; Yang Z; Zheng J; Wang Y; Gao Y
    Int J Med Sci; 2019; 16(5):644-653. PubMed ID: 31217731
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension.
    Alawi LF; Dhakal S; Emberesh SE; Sawant H; Hosawi A; Thanekar U; Grobe N; Elased KM
    Front Pharmacol; 2020; 11():602985. PubMed ID: 33708117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trientine and renin-angiotensin system blockade ameliorate progression of glomerular morphology in hypertensive experimental diabetic nephropathy.
    Moya-Olano L; Milne HM; Robinson JM; Hill JV; Frampton CM; Abbott HF; Turner R; Kettle AJ; Endre ZH
    Pathol Int; 2011 Nov; 61(11):652-61. PubMed ID: 22029676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of arterial hypertension in the progression of non-diabetic glomerular diseases.
    Ljutić D; Kes P
    Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v28-30. PubMed ID: 12817064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats.
    Park HW; Kim Y; Kim KH; Jeong HJ; Shin MH; Rozen S; Mauer M
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):110-7. PubMed ID: 17907098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.